InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（9 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
9
T+90 胜率
100%
T+90 平均收益
+21.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Curran Terrie, 董事长兼首席执行官. Insider active across 3 companies, notably Myovant Sciences Ltd.. Cumulatively, 29 filings have been recorded. Split: 2 buys · 9 sells. Total volume traded: €1.8m. History available since 1 September 2021. The latest transaction was disclosed on 27 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Curran Terrie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报29 总计
11,148 股@ US$7.51Common StockSEC:0001628280-26-059444:0
11,148 股@ US$25.0294Common StockSEC:0001628280-26-059444:1
27,052 股@ US$8.63Common StockSEC:0001628280-26-059444:2
27,052 股@ US$25.0294Common StockSEC:0001628280-26-059444:3
1,072 股@ US$7.510.0003% mcap5.8% 占其流量Common StockSEC:0001628280-26-058648:0
1,072 股@ US$26.03760.0009% mcap20.1% 占其流量Common StockSEC:0001628280-26-058648:1
5,778 股0Common StockSEC:0001628280-26-042042:0
7,609 股0Common StockSEC:0002065881-25-000025:0
19,109 股@ US$6.587713.6% 占其流量Common StockSEC:0000950170-25-008348:0
8,687 股@ US$10.8482100.0% 占其流量Common StockSEC:0001787306-24-000155:0
33,848 股@ US$11.7240.9% 占其流量Common StockSEC:0000950170-24-084179:0
10,139 股0Common StockSEC:0001787306-24-000103:0
16,851 股@ US$9.1115.9% 占其流量Common StockSEC:0000950170-24-036398:0
37,500 股0Common StockSEC:0001209191-23-054346:0
200,000 股Common StockSEC:0001209191-23-042454:0
4,375 股0Common StockSEC:0001787306-23-000058:0
12,919 股@ US$7.819910.4% 占其流量Common StockSEC:0001209191-23-023751:0
标准退出：2023年7月5日 (T+90)
3,673 股Common SharesSEC:0001209191-23-017716:0
1,436 股@ US$8.54111.3% 占其流量Common StockSEC:0001209191-23-016002:0
97,500 股0Common StockSEC:0001209191-23-004341:0
1,526 股@ US$9.601.6% 占其流量Common StockSEC:0001209191-22-058619:0
9,859 股0Common SharesSEC:0001209191-22-054817:0
7,500 股0Common StockSEC:0001209191-22-048472:0
4,312 股0Common StockSEC:0001567619-22-012323:0
12,000 股0Common StockSEC:0001209191-22-031080:0
29 条申报中的 25 条
About Curran Terrie
Curran Terrie is President and Chief Executive. There are 23 filings in total. In the 23 sampled recent filings, buys total EUR 238796 and sells total EUR 739746, covering the period from 2021-09-03 to 2026-06-09. The largest transactions involve Phathom Pharmaceuticals, Inc. and Arcutis Biotherapeutics, Inc., including a sell of EUR 363891.5667780492 on 2024-07-17 and a buy of EUR 146282.6807715701 on 2022-05-16.
